Validation of the REPS Prediction Tool

CompletedOBSERVATIONAL

Enrollment

101,510

Participants

Timeline

Start Date

June 29, 2018

Primary Completion Date

December 10, 2019

Study Completion Date

December 31, 2020

Conditions

Residual Neuromuscular BlockadeCurarization, Postoperative ResidualPostoperative Respiratory Complication

Interventions

OTHER

Observational Study

Observational Study: Not Applicable for Observational Studies

Trial Locations (1)

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

lead

Beth Israel Deaconess Medical Center

OTHER

NCT03585400 - Validation of the REPS Prediction Tool | Biotech Hunter | Biotech Hunter